| Jandra Oliver, MSN, PMHNP-BC | |
|
72 Harrel St, Morrisville, VT 05661-8526 | |
| (802) 301-3747 | |
| (802) 888-6393 |
| Full Name | Jandra Oliver |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 72 Harrel St, Morrisville, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033673181 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Jandra Oliver, MSN, PMHNP-BC 72 Harrel St, Morrisville, VT 05661-8526 Ph: (802) 888-5026 | Jandra Oliver, MSN, PMHNP-BC 72 Harrel St, Morrisville, VT 05661-8526 Ph: (802) 301-3747 |
News Archive
Penetrating injury rates were more than 20 times higher for persons living in the lowest income neighborhoods compared with those living in the highest income neighborhoods, according to a new study published in the August issue of the Journal of the American College of Surgeons. Researchers also found that those in the lowest-income neighborhoods experienced nearly six times higher rates of blunt injury than persons in the highest income neighborhoods. Penetrating injuries included those from firearms or cuts; blunt injuries included motor vehicle crashes, falls and assaults.
U.S. Pharmacopeia (USP) Convention, an official public standards-setting authority for all prescription and over-the-counter medicines sold in the United States, on December 4, 2008 transferred all rights, ownership and management of the overall MEDMARX reporting program to Quantros.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
Genetic mutations are a major cause of cancer, and tracking the role of each gene in cancer pathogenesis has long been an important tool in the fight against a disease that is expected to kill more than 1.6 million people this year.
› Verified 6 days ago
Dr. Molly Heller, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 109 Professional Dr, Morrisville, VT 05661 Phone: 801-851-0999 | |
Alexander C. Johnston, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 65 Northgate Plaza, Suite 11, Morrisville, VT 05661 Phone: 802-888-8320 Fax: 802-888-8136 | |
John-paul Cloutier, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 607 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-8320 | |
Steacy Lynne Suddaby, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-5639 Fax: 802-888-6040 | |
Elizabeth Ashley Douglas, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 609 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-5639 | |
Elizabeth Hanna Steiner, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 528 Washington Hwy, Morrisville, VT 05661 Phone: 802-888-8372 Fax: 802-888-8131 | |
Susan Allen Hooper, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 528 Washington Highway, Acu, Morrisville, VT 05661 Phone: 802-888-8372 Fax: 802-888-8131 |